Targeted Genetics Corporation and University College London Participate in “Gene Therapy Horizons” Press Conference

BOSTON, MA and SEATTLE, WA--(Marketwire - May 29, 2008) - Targeted Genetics Corporation (NASDAQ: TGEN) and University College London today announced participation in the third annual "Gene Therapy Horizons" Lecture at the 11th Annual Meeting of the American Society of Gene Therapy taking place this week at the Hynes Convention Center in Boston.
MORE ON THIS TOPIC